Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. [electronic resource]

By:

Gleissner, Beate

Contributor(s):

Schlenk, Richard
Bornhäuser, Martin
Berdel, Wolfgang E

Producer: 20080104Description: 657-62 p. digitalISSN:

1423-0240

Subject(s):

Aminoglycosides -- administration & dosage
Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents -- administration & dosage
Clinical Trials as Topic -- trends
Gemtuzumab
Germany
Humans
Leukemia, Myeloid, Acute -- drug therapy
Practice Patterns, Physicians' -- trends
Treatment Outcome

Online resources:

Available from publisher's website

In: Onkologie vol. 30

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

Browse results Close

Back to results

1 [The inhibitive effect of sodium tanshinone II A sulfonic acid on intimal hyperplasia in rabbit iliac artery ballon injury model].
by Chen, Yu-cheng
2 Impact of a dedicated training program on the reproducibility of systolic dyssynchrony measures using tissue Doppler imaging.
by Zhang, Qing
3 Decreased left atrial myocardial strain in patients with suboptimal blood pressure control.
by Chen, Xiao-Jing
4 LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome.
by Lee, Alex Pui-Wai
5 Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy.
by Liang, Yu-Jia
6 [Visualization of right atrial flow patterns and quantification of pulmonary to systemic flow ratio in patients with atrial septal defect by vector flow mapping].
by Wei, Xin
7 Higher blood pressure control rate in a real life management program provided by the community health service center in China.
by Chen, Xiao-Jing
8 Uncontrolled blood pressure as an independent risk factor of early impaired left ventricular systolic function in treated hypertension.
by Chen, Xiao-Jing
9 Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography.
by Yip, Gabriel Wai-Kwok
10 Incremental value of global systolic dyssynchrony in determining the occurrence of functional mitral regurgitation in patients with left ventricular systolic dysfunction.
by Liang, Yu-Jia
11 Different determinants of improvement of early and late systolic mitral regurgitation contributed after cardiac resynchronization therapy.
by Liang, Yu-Jia
12 Difference in prevalence and pattern of mechanical dyssynchrony in left bundle branch block occurring in right ventricular apical pacing versus systolic heart failure.
by Zhang, Qing
13 Left ventricular systolic dyssynchrony in acute decompensated heart failure.
by Lee, Alex Pui-Wai
14 Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
by Zhang, Qing
15 A novel multi-layer approach of measuring myocardial strain and torsion by 2D speckle tracking imaging in normal subjects and patients with heart diseases.
by Zhang, Qing
16 [Functional Analysis of DNA Damage Repair Factor WDR70 and Its Mutation in Ovarian Cancer].
by Guo, Lian-di

Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.

APA

Gleissner B., Schlenk R., Bornhäuser M. & Berdel W. E. (20080104). Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. : Onkologie.

Chicago

Gleissner Beate, Schlenk Richard, Bornhäuser Martin and Berdel Wolfgang E. 20080104. Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. : Onkologie.

Harvard

Gleissner B., Schlenk R., Bornhäuser M. and Berdel W. E. (20080104). Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. : Onkologie.

MLA

Gleissner Beate, Schlenk Richard, Bornhäuser Martin and Berdel Wolfgang E. Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. : Onkologie. 20080104.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC